Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma

This subset analysis of data from two phase III studies in patients with relapsed or refractory multiple myeloma (MM) evaluated the benefit of initiating lenalidomide plus dexamethasone at first relapse. Multivariate analysis showed that fewer prior therapies, along with β(2)-microglobulin (≤2.5 mg/...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Stadtmauer, Edward A, Weber, Donna M, Niesvizky, Ruben, Belch, Andrew, Prince, Miles H, San Miguel, Jesús F, Facon, Thierry, Olesnyckyj, Marta, Yu, Zhinuan, Zeldis, Jerome B, Knight, Robert D, Dimopoulos, Meletios A
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2009
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2704925/
https://ncbi.nlm.nih.gov/pubmed/19302559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-0609.2009.01257.x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki